Atomo Diagnostics (ASX:AT1) said it secured a AU$450,000 order from the National Association of People with HIV Australia for HIV self-tests, according to a Tuesday filing with the Australian bourse.
The revenue from this order is material, the filing said.
Shares of the company fell 6% in recent Tuesday trade, earlier hitting an all-time low.